AIM has no minimum market cap, no minimum trading history, and no revenue requirements. It is designed specifically for companies in NWBO’s exact position. The Reality: NWBO already has an active instrument (0K95) on the London Stock Exchange. Claiming they "can't list" in a city where they already own a multimillion-pound manufacturing facility (Sawston) and a UK subsidiary (Advent Bio) is objectively disconnected from reality.